Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Searching for fast money? Discover the best places to sell items for quick cash and get paid almost instantly.
15,258 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
A shift of production back to the United States is yielding more than branding for a leading self-defense maker. The ...
A high-profile export case links AI hardware, sanctions, and risk for investors. This article breaks down what happen...
Seven months into fiscal 2026, the deficit surged to $955 billion, intensifying pressure on policymakers to restrain ...
As Walmart gears up for 2027, investors need a clear view of how groceries, online sales, and international markets s...
IBM argues that data gravity keeps information in place. This investing piece explains why that matters, how AI reinf...
Spotify and Netflix released new quarterly results, highlighting diverging growth paths. One shows steady subscriber ...
A seasoned investor’s eye looks beyond a single insider trade. This article breaks down why this limited insider sale...
As Agilent prepares to reveal its Q1 2026 results, investors want clarity on growth signals and margins. This guide b...
Restaurant Brands International has risen 6.7% in 2026, trading around $73.36, but retail investors on Reddit remain ...
This article breaks down the key themes from the semiconductor 2025 earnings call, highlighting demand cycles, margin...
When a blue‑chip like Cisco posts a solid beat and raises guidance, the stock often jumps. This article breaks down t...